I was seeing a tremendous amount of people coming in just with nausea, vomiting, and feelings of fullness, early satiety, just not feeling well Universally these patients were on GLP-1s. Boxer said there are two main issues when it comes to treating patients with these symptoms
Additionally, people with a history of heart problems can choose semaglutide without concern for high blood pressure or an accelerated heart rate
References ClinicalTrials.gov
Regular monitoring is key when a patient is on Tirzepatide, especially if they are taking other medications
Semaglutide vs Retatrutide: Head-to-Head Comparison Why Retatrutides Triple Agonism Matters for Research The addition of glucagon receptor agonism creates a fundamentally different metabolic profile
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for managing type 2 diabetes mellitus (under brand names Ozempic and Rybelsus) and chronic weight management (Wegovy)